CHAPTER TWO

LITERATURE REVIEW

2.0 Review of relevant literature

2.1 Conceptual Review

2.1.1 Concept of Urinary Tract infection

2.1.2 Classification of Urinary Tract Infections

2.1.3 Etiology and Causative Agents of UTIs

2.1.4 Epidemiology and Global Prevalence of UTIs

2.1.5 Prevalence of UTIs in Africa and Developing Countries

2.1.6 Prevalence of UTIs in Nigeria

2.1.7 Prevalence of UTIs in Ogun State Hospital

2.1.8 Determinants associated with UTI Prevalence

2.1.9 Risk Factors associated with UTI Prevalence

2.1.10 Antibiotic Resistance and UTI Treatment Challenges

2.1.11 Symptoms and Clinical Diagnosis of UTIs

2.1.12 Demographic Patterns in UTI Occurrence

2.1.13 UTIs in Special Populations (e.g., pregnant women, elderly, diabetics)

2.1.14 UTI Prevention and Health Education Strategies

2.1.15 Healthcare System Response to UTI Management

2.2 Theoretical Review

2.2.1 Health Belief Model (HBM)

2.2.2 Germ Theory of Disease

2.3 Empirical Review

2.4 Appraisal of Reviewed Literature

2.1 Conceptual Review

2.1.1 Concept of Urinary Tract infection

A urinary tract infection (UTI) is an inflammation of the urinary system involving the urethra,

bladder, ureters, or kidneys, and typically results from microbial invasion of the normally

sterile urinary tract (Dechasa et al., 2023). UTIs can manifest as lower urinary infections,

such as cystitis and urethritis, or as upper infections like pyelonephritis, which affects the

kidneys (Hooton et al., 2022). The pathogenesis often begins with uropathogenic Escherichia

coli (UPEC), which accounts for approximately 90% of community-acquired UTIs. UPEC

adheres to urothelial cells via pili and adhesins, ascends from the urethra to the bladder and

beyond, and may invade bladder epithelial layers, forming biofilms and intracellular

reservoirs that contribute to recurrent infections (Tabassum et al., 2022). Pyuria or the

presence of white blood cells in urine is a hallmark of UTI, reflecting the host's inflammatory

response, and diagnosis commonly relies on urinalysis, including dipstick tests and

microscopic examination ([Link], 2025).

Globally, UTIs impose a significant healthcare burden, affecting around 150 million

individuals yearly and causing approximately 196,500 deaths annually. A meta-analysis

reported a worldwide incidence of around 1.6%, with the African region experiencing a

higher rate of 3.6% compared to global averages (Mengistu et al., 2023). In the United States,

over 60% of women will experience a UTI during their lifetime, while the disease burden

increased by 68% from 1990 to 2019, largely driven by antibiotic resistance and demographic

factors (National Post, 2024). By contrast, uncomplicated UTIs may self-resolve, especially

in asymptomatic cases, though they carry risks including progression to pyelonephritis,

sepsis, or complications in pregnancy thus antibiotic therapy remains the standard of care

(VerywellHealth, 2025).
In Africa, diagnostic and management challenges are compounded by resource limitations. A

study across Africa demonstrated that nearly 90 million UTI patients globally experience

barriers to accurate testing and treatment (Mengistu et al., 2023). Within Nigeria specifically,

several recent studies highlight both the epidemiology and antimicrobial resistance profiles of

uropathogens. Ajayi et al. (2024) assessed UTIs in Ado-Ekiti, revealing an 8.5% prevalence

of UTI among hospital and community participants, with Escherichia coli and Klebsiella

species dominant. Extremely high resistance rates were observed: up to 91.5% of isolates

resisted amoxicillin-clavulanate, while imipenem retained 85.1% efficacy it was concluded

that recurrent UTIs and misuse of antibiotics necessitate ongoing surveillance and prudent

prescribing (Ajayi et al., 2024).

Similarly, Bassey et al. (2025) at Calabar investigated antibiotic resistance among

uropathogens. They isolated Klebsiella pneumoniae, S. aureus, and E. coli among others,

finding alarming multidrug resistance profiles. Augmentin and amoxicillin were largely

ineffective, though susceptibility to levofloxacin and ciprofloxacin remained high. The

authors recommended targeted antimicrobial therapy guided by local resistance patterns

(Bassey et al., 2025).

Focusing on vulnerable groups, Ogidi, Southeast Nigeria, Ekwealor et al. (2024) noted a

24.2% UTI prevalence among pregnant women. The most prevalent pathogens included E.

coli (24.1%) and Klebsiella species (18.5%). Gram-negative bacteria were mainly sensitive to

cefuroxime, while Gram-positive organisms responded well to levofloxacin but were highly

resistant to amoxicillin. Ekwealor et al. concluded that proper diagnosis and antibiotic

susceptibility testing are vital, especially in pregnancy when untreated UTIs can result in

pyelonephritis, preterm birth, and perinatal mortality (Ekwealor et al., 2024).

Moreover, under-five febrile children in Owerri had an 18.8% UTI prevalence, with most

cases asymptomatic. Nwigwe et al. (2024) argued for routine UTI screening in febrile
pediatric patients to guide empirical therapy and prevent complications. Among geriatric

patients in Ibadan, Adeniyi et al. (2024) found a 21.4% UTI prevalence in individuals over

65. Men exhibited a higher infection rate than women. E. coli and K. pneumoniae were

predominant, and many isolates resisted first-line antibiotics. Adeniyi et al. emphasized the

necessity of antibiotic stewardship in older adults to curb rising resistance and preserve

effective treatment options.

Another concern is the emergence of carbapenemase-producing organisms. A study at

University College Ibadan found that 9.2% of UTI cases involved carbapenemase-producing

bacteria primarily K. pneumoniae, E. coli, and Pseudomonas aeruginosa. This was

particularly alarming given these drugs are often used as last-resort treatments. The study

underscored the need for infection control and surveillance to limit the spread of these

resistant strains (Sokoto Journal, 2024). Extended-spectrum β-lactamase (ESBL)-producing

K. pneumoniae in Keffi were detected with a prevalence of 12.5%. These strains showed

100% resistance to ceftazidime and nearly complete resistance to ceftriaxone and cefuroxime,

yet remained somewhat responsive to ofloxacin and amoxicillin. The study recommended

strengthening primary health centers within antimicrobial stewardship programs (Ayeni et al.,

2024).

These Nigerian data reflect a broader trend across Africa, where antimicrobial resistance

complicates UTI treatment and underscores a need for regionally tailored antibiotic policies.

The increasing prevalence of drug-resistant strains jeopardizes standard empirical therapies

and heightens risks of severe outcomes such as pyelonephritis, sepsis, and neonatal

morbidity.

Globally, insights into UTI pathogenesis and prevention continue to evolve. UPEC virulence

mechanisms, such as fimbrial adhesion and biofilm formation, illustrate the difficulty in

eradicating chronic infections and support new approaches focusing on pathogen-blocking

vaccines or probiotic interventions (Wikipedia, 2025; VerywellHealth, 2024). Research into

gut microbiome restoration and cranberry supplementation also offers non-antibiotic

preventive strategies, showing promising trends particularly for recurrent UTI in women

(Daily Telegraph, 2024).

The summer season increases UTI risk due to dehydration and bacterial proliferation linked

to high temperatures and humidity. Wearing wet swimwear and poor hydration exacerbate

susceptibility (New York Post, 2025). Prompt hydration and hygiene practices, alongside

urinary alkalinization strategies, may have protective effects. The concept of UTI

encompasses a wide spectrum of clinical presentations and microbial causes from benign

cystitis to life-threatening pyelonephritis and septicemia. While UPEC remains the primary

pathogen, other bacteria and fungi may also cause infections. Globally, UTIs affect millions

annually, though incidence appears to be decreasing in some regions. However, Africa,

particularly Nigeria, experiences persistently high prevalence and significant antimicrobial

resistance. The rise of multidrug-resistant, ESBL, and carbapenemase-producing strains

demands vigilant surveillance, accurate diagnostics, antibiotic stewardship, and consideration

of non-antibiotic prevention strategies. Integrating global pathophysiological insights with

local epidemiological data offers the best route to managing UTIs effectively in resource-

limited settings.

2.1.2 Classification of Urinary Tract infection

A urinary tract infection (UTI) is defined as an inflammatory response of any part of the

urinary tract kidneys, ureters, bladder, or urethra typically resulting from microbial invasion.

Among the primary causative agents, uropathogenic Escherichia coli (UPEC) predominates,

accounting for approximately 80–90% of community-acquired UTIs due to its expression of

virulence factors such as P fimbriae that promote adhesion to uroepithelial cells (Wikipedia,
2025; Pathogenic E. coli, 2025). Clinicians and researchers classify UTIs into categories

predicated on anatomical location, patient risk factors, microbiological profiles, and care

setting, enabling tailored diagnosis and management strategies.

An internationally recognized classification, endorsed by the European Association of

Urology (EAU) and European Section of Infection in Urology (ESIU), distinguishes between

uncomplicated and complicated UTIs. Uncomplicated UTIs occur in otherwise healthy,

nonpregnant individuals with normal genitourinary anatomy and function often presenting as

isolated lower urinary tract illness such as cystitis. In contrast, complicated UTIs involve host

factors or anatomical abnormalities that elevate risk and severity; these include pregnancy,

diabetes, renal pathology, indwelling catheters, or immunosuppression (Smelov et al., 2016;

Wagenlehner et al., 2020). The ORENUC risk-stratification model furthers this by

categorizing patients based on recurrence risk (R), extraurogenital risk (E), nephropathic

disease (N), urological risk (U), catheterization (C), or absence of risk factors (O) (Smelov

et al., 2016).

Anatomically, UTIs are classified into lower and upper tract infections. Cystitis, an infection

of the bladder, typically manifests with dysuria and frequency and is often uncomplicated

when occurring in healthy individuals (Clinical Medicine and Health Research Journal,

2024). Pyelonephritis, affecting the renal parenchyma and upper tract, presents more severe

systemic signs and qualifies as upper tract infection. Pyelonephritis may also be classified as

uncomplicated or complicated, depending on patient risk factors such as pregnancy or renal

transplants (Clinical Medicine and Health Research Journal, 2024).

The setting of UTI acquisition community versus hospital also defines classification.

Community-acquired UTIs are often caused by E. coli and managed empirically in most

primary care settings. Nosocomial or healthcare-associated UTIs (HA-UTIs) involve more

resistant organisms, such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and

Enterococcus species, frequently linked to catheterization or invasive procedures. In a tertiary

hospital in South Eastern Nigeria, E. coli (28.5%) and Staphylococcus aureus (28%)

dominated community-related UTIs, whereas nosocomial infections showed more diverse

uropathogens. This underscores the need for different empirical treatments tailored to care

settings (Bassey et al., 2025).

Age, gender, and comorbidities also shape UTI classification and risk. Women between 16

and 35 years old repeatedly demonstrate high incidence due to urethral anatomy (Dechasa et

al., 2023), and meta-analyses estimate global UTI incidence peaking at 1.6%, with Africa

reporting up to 3.6% (Mengistu et al., 2023). In rural Enugu, Nigeria, 88.3% of community

urine cultures were positive; E. coli represented 48.7% of isolates, followed by staphylococci

(27.7%), most frequently in women aged 31–40 (Chinedu et al., 2022). Among geriatric

patients in Ibadan, E. coli (40.9%) and Klebsiella pneumoniae (29.5%) were predominant;

men exhibited higher UTI rates than women, which may relate to underlying prostatic

pathology (Adeniyi et al., 2024). Such demographic differentiation informs tailored

prevention and treatment protocols.

Microbiological classification further distinguishes UTIs based on pathogen types. Gram-

negative rods cause 80–90% of UTIs (Bassey et al., 2025; Wikipedia, 2025), including E.

coli, Klebsiella pneumoniae, Proteus, Pseudomonas, and Enterobacter species. Gram-

positive organisms (S. aureus, Enterococcus) are also frequently implicated, especially in

hospital settings and catheter-associated cases (Oli et al., 2017). In Calabar, Klebsiella

pneumoniae (23.1%) surpassed E. coli (12.3%) among isolates, highlighting regional

variation (Bassey et al., 2025).

Increasing antimicrobial resistance (AMR) further nuances UTI classification. Multidrug-

resistant (MDR) UTIs those resistant to ≥3 antibiotic classes pose therapeutic challenges. In
Calabar, MDR prevalence among uropathogens reached 39%, with Klebsiella and E. coli

displaying high resistance to augmentin, amoxycillin-clavulanate, erythromycin, and

rifampicin but retained susceptibility to fluoroquinolones, gentamicin, and ciprofloxacin

(Bassey et al., 2025). Nigerian pediatric data from Abuja identified MDR rates of 39%,

supporting second-generation fluoroquinolones as effective empiric therapy (Adedare et al.,

2024). These findings promote classification of resistant UTIs and support culture-directed

therapies.

Recurrent UTIs defined by two or more episodes within six months or three within one year

represent a distinct classification subset, often involving similar pathogens and host

vulnerabilities. UPEC strains typically recur due to biofilm formation or intracellular

reservoirs in the urothelium (Wikipedia, 2025). Although specific data on Nigeria's

recurrence rates is sparse, high incidence among women, diabetics, and catheterized patients

suggests the presence of recurrent or persistent infection patterns (Chinedu et al., 2022;

Adeniyi et al., 2024).

Asymptomatic bacteriuria (ASB), defined by ≥10⁵ CFU/mL in a patient lacking symptoms, is

a distinct classification for which treatment is generally recommended only in specific

circumstances such as pregnancy or before urological procedures (PubMed 37906240;

Wikipedia, 2025). This distinction prevents overtreatment and antibiotic resistance.

Diagnostic thresholds also reflect classification standards. Traditional urine culture cutoffs of

≥10⁵ CFU/mL in clean-catch midstream specimens are evolving; culture-confirmed pyuria

with 10³–10⁴ CFU/mL often warrants treatment in symptomatic UTIs or catheter-associated

cases (PubMed 37426954; Wikipedia, 2025). These adaptations reflect nuanced

understanding of infection dynamics and pathogen load.

2.1.3 Etiology and Causative Agents of UTIs

A urinary tract infection (UTI) is defined as the invasion and multiplication of pathogenic

microorganisms in any part of the urinary system, including the urethra, bladder, ureters, and

kidneys (Shaikh et al., 2020). Anatomically, UTIs are categorized into lower tract infections

such as cystitis and urethritis and upper tract infections, including pyelonephritis (Shaikh et

al., 2020). Globally, UTIs are among the most common infectious diseases, with an estimated

150 million cases annually and costing over US $6 billion in healthcare expenditure (Tadesse

et al., 2022). The burden is disproportionately high in women due to anatomical differences,

such as shorter urethral length and proximity to the anus, which facilitate pathogen ascent

into the urinary tract (Shaikh et al., 2020).

The global etiology of UTIs is dominated by bacterial pathogens, with Escherichia coli

emerging as the most frequent culprit. This uropathogenic E. coli (UPEC) is responsible for

approximately 80–90% of community-acquired UTIs worldwide (Wikipedia, 2025; Tadesse

et al., 2022). UPEC exhibits specialized virulence factors including P fimbriae and

hemolysins that enable adherence to urothelial cells and survival in the urinary tract via

mechanisms like intracellular bacterial community formation and biofilm production

(Wikipedia, 2025). These traits explain its predominance in both lower and upper UTIs.

Following E. coli, other notable global pathogens include Klebsiella spp., Proteus spp.,

Enterococcus spp., Pseudomonas aeruginosa, and Staphylococcus aureus, especially in

healthcare settings (Wikipedia, 2025; Tadesse et al., 2022). Gram-positive cocci such as

Enterococcus and S. aureus represent a growing concern due to increasing resistance patterns.

Additionally, rare non-bacterial causes including Candida albicans in catheterized patients,

and viral or parasitic etiologies have been reported (Shaikh et al., 2020; Mwang’onde &

Mchami, 2022).

In Sub-Saharan Africa, a systematic review spanning 2000 to 2021 across several countries

reported a UTI prevalence of 32.1%, with a striking dominance of E. coli among isolates
(86.4%), followed by Klebsiella, Staphylococcus, Proteus, and Enterococcus (Mwang’onde

& Mchami, 2022). The prevalence varied regionally, with Nigeria at 43.7%, South Africa at

67.6%, and other countries ranging from 18.5% to 38.3% (Mwang’onde & Mchami, 2022).

Among people living with HIV in Africa, the pooled prevalence was 24%, with E. coli again

the most frequently isolated pathogen (n = 855 out of 1,783 isolates), and immunosuppression

and female sex identified as significant risk factors (Shabohurira et al., 2025).

Focusing on Nigeria, national studies reflect consistent trends seen globally and regionally.

For instance, a rural Nigerian community study reported an overall UTI prevalence of 39.7%,

with higher rates among females (42.8%) versus males (10.2%), and E. coli as the

predominant isolate overall and among females; in males, S. aureus was most common

(Ibadin et al., 2012). Another large-scale analysis of 12,458 urine samples found a

community-acquired UTI prevalence of 12.3% and hospital-acquired infections at 9.3%, with

female prevalence at 14.6% compared to 7.4% in males; E. coli accounted for 61.2% of

isolates, followed by S. aureus (14.9%), Klebsiella pneumoniae (5.9%), Enterococcus faecalis

(5.6%), Morganella morganii (4.8%), Citrobacter spp., Acinetobacter, Enterobacter, and P.

aeruginosa each under 2% (Oladele et al., 2019). In children, a combined study of urine and

stool cultures at a tertiary hospital in Abuja confirmed E. coli as the leading pathogen, noting

suboptimal antibiotic susceptibility and a high incidence of multidrug resistance (Adewale et

al., 2024).

In southwestern Nigeria, teaching hospital data indicated predominant uropathogens as E.

coli (48%), Klebsiella spp. (24%), S. aureus (10%), and coagulase-negative staphylococci

(6.5%) (Onifade et al., 2016). A tertiary institution in Abuja observed similar bacterial

profiles alongside growing resistance to common antibiotics (Onifade et al., 2016; Adewale

et al., 2024). These patterns underscore the need for periodic, locale-specific etiologic

profiling to guide empirical therapy. The etiology of UTIs is significantly influenced by risk
factors. Globally, female anatomy, sexual activity, pregnancy, diabetes, obesity, catheter use,

and immunosuppression are recognized contributors (Wikipedia, 2025; Shaikh et al., 2020).

In Sub-Saharan Africa and Nigeria specifically, poverty, poor hygiene, malnutrition, and

limited access to healthcare are additional drivers, especially in rural settings (Ibadin et al.,

2012; Mwang’onde & Mchami, 2022). Among people living with HIV, low CD4 counts

(<200 cells/mm³) correlate with higher UTI risk (Shabohurira et al., 2025).

Understanding etiopathogenesis is crucial. Ascending infection remains the dominant

pathway enteric bacteria like E. coli colonize the perineum and vagina, ascend through the

urethra, and infect the bladder and kidneys (Shaikh et al., 2020; Wikipedia, 2025). In

catheterized patients, biofilm formation on catheter surfaces facilitates colonization by a

broader array of nosocomial pathogens (Wikipedia, 2025). Rarely, hematogenous spread may

cause pyelonephritis or prostatitis, particularly with S. aureus (Wikipedia, 2025).

UTIs are globally and regionally significant, impacting hundreds of millions each year.

Bacterial pathogens are responsible for over 95% of infections, with E. coli consistently the

leading agent across global, African, and Nigerian contexts. Other frequent pathogens include

Klebsiella, Proteus, Enterococcus, Pseudomonas, and Staphylococcus species. Risk factors

and resistance patterns vary by geography and population, making region-specific

surveillance essential. In Nigeria, recent studies affirm these trends and highlight growing

antibiotic resistance, emphasizing the need for ongoing etiologic monitoring and

antimicrobial stewardship.

2.1.4 Epidemiology and Global Prevalence of UTIs

Urinary tract infections (UTIs) are among the most common bacterial infections affecting

humans, particularly women, and pose a significant health burden worldwide. They manifest

when microbes invade the urinary tract encompassing the urethra, bladder, ureters, or kidneys

overcoming the body’s defensive mechanisms. Gram-negative bacteria, especially

uropathogenic Escherichia coli (UPEC), dominate the etiological landscape, but Gram-

positive bacteria and fungi have also emerged as noteworthy causative agents.

Globally, UPEC continues to be the primary pathogen, responsible for approximately 75–

90 percent of community-acquired uncomplicated UTIs (Neves et al., 2024). In a

comprehensive global review, it was reported that UPEC accounts for nearly 80 percent of

uncomplicated and complicated UTIs, followed by Klebsiella pneumoniae, Staphylococcus

saprophyticus, Enterococcus faecalis, group B Streptococcus, Proteus mirabilis,

Pseudomonas aeruginosa, Staphylococcus aureus, and Candida species (Neves et al., 2024).

These patterns reflect the variable distribution of pathogens based on severity, complexity,

and geographic region.

In sub-Saharan Africa broadly, E. coli remains the dominant uropathogen, constituting over

half of all isolates estimated at around 51.4 percent followed by K. pneumoniae (4.1 percent),

P. mirabilis (3.3 percent), and Enterococcus faecalis (2.5 percent). A recent continent-wide

analysis revealed that approximately one in four people living with HIV are at heightened

risk for UTI, emphasizing the pressing need for improved diagnostic and therapeutic

strategies to mitigate this burden. Turning to Nigeria, recent studies illustrate a consistent

pattern of E. coli predominance. In a study from Kaduna examining pregnant women, E. coli

was identified as the leading pathogen, with poor perineal hygiene emerging as a major risk

factor (Dechasa et al., 2023). A retrospective 5-year analysis of pediatric urine cultures in

Abuja likewise confirmed E. coli as the principal agent, with a 29 percent positivity rate;

competing organisms included Klebsiella, Pseudomonas, and Enterococcus. Moreover,

Nigerian research highlights that antibiotic resistance complicates the clinical landscape, with

only fluoroquinolones such as levofloxacin retaining potency against the most common

isolates.
Additional studies within Nigeria reinforce the link between hygiene, demographic factors,

and high UTI prevalence. Malnutrition, poor sanitation, and low socioeconomic status

prevalent in rural communities elevate UTI risk, where UPEC prevails and antibiotic

resistance is increasingly reported. While Gram-negative rods dominate, Gram-positive

bacteria and fungi also contribute meaningfully, especially in special populations.

Staphylococcus saprophyticus, a Gram-positive organism, is responsible for up to 10 percent

of community-acquired UTIs in young women globally. Enterococcus faecalis is frequently

implicated in both complicated infections and asymptomatic bacteriuria, particularly among

pregnant or catheterized patients. Raw data from Bangladesh, while outside the strict scope of

Africa, underscores the global presence of Gram-positive uropathogens: Enterococcus spp.

(33 percent), Staphylococcus aureus (27 percent), and Streptococcus spp. (20 percent) were

noted as significant causative agents.

Fungal infections, though less common, are notable in immunocompromised or catheterized

individuals. Candida species especially Candida albicans account for roughly 9 percent of

healthcare-associated UTIs, including catheter-associated infections. Catheter-associated

urinary tract infections (CAUTIs) across Africa display a similar mix: Gram-negatives

dominate (82.9 percent), led by E. coli (45.1 percent) and Klebsiella spp. (24.2 percent);

Gram-positive contributors include Staphylococcus aureus (53.2 percent of Gram-positives) .

A pressing concern across Nigeria and Africa is antimicrobial resistance (AMR). Extended-

spectrum beta-lactamase (ESBL)-producing and metallo-beta-lactamase–producing E. coli

and Klebsiella have been increasingly detected (Azubuike et al., 2023; Rahman et al., 2023),

presenting serious treatment challenges. In Abuja, pediatric isolates showed suboptimal

susceptibility to first-line agents such as amoxicillin–clavulanate and cotrimoxazole, though

levofloxacin remained effective. Similarly, Klebsiella spp. and Pseudomonas strains exhibited

significant multi-drug resistance in Nigerian cohorts.

Host factors also influence UTI etiology and susceptibility. Female anatomy with a shorter

urethra and proximity to the anus predisposes to ascending infections. Additional risk factors

include sexual activity, hormonal changes, pregnancy, catheterization, immunosuppression,

diabetes, and structural urinary abnormalities like vesicoureteral reflux. In Nigeria, conditions

such as malnutrition and sickle cell disease have also been noted as contributing factors. The

etiology of UTIs globally, in Africa, and specifically in Nigeria is dominated by UPEC, with

secondary roles for Klebsiella, Proteus, Pseudomonas, Enterococcus, Staphylococcus, and

Candida. Regional studies underscore the consistent prevalence of E. coli across

demographic groups, and highlight the compounding factors of poor hygiene, socioeconomic

constraints, pregnancy, catheter use, and antimicrobial resistance. These challenges

underscore the urgent need for ongoing surveillance, improved antimicrobial stewardship,

targeted hygiene interventions, and local susceptibility profiling to guide effective therapy.

2.1.5 Prevalence of UTIs in Africa and Developing Countries

Urinary Tract Infections (UTIs) are among the most common bacterial infections affecting

individuals globally, with a disproportionately higher burden observed in Africa and other

developing countries. UTIs are infections that affect any part of the urinary system, including

the kidneys, ureters, bladder, and urethra. They are primarily caused by bacterial pathogens,

particularly Escherichia coli, which is responsible for approximately 80–90% of community-

acquired infections. The prevalence and management of UTIs in Africa and other developing

regions have become a significant public health concern due to poor sanitation, inadequate

healthcare infrastructure, and rising antimicrobial resistance.

In developing countries, the prevalence of UTIs is influenced by a range of socioeconomic

and environmental factors. Inadequate access to clean water, poor personal hygiene, limited

availability of diagnostic facilities, and inappropriate use of antibiotics contribute

significantly to the high incidence of UTIs (Okonko et al., 2023). According to a cross-
sectional study conducted in Nigeria, the overall prevalence of UTIs among symptomatic

patients in tertiary hospitals was recorded at 29.5%, with a higher occurrence in females than

males, largely due to anatomical and physiological differences (Afolabi et al., 2023). This

pattern is consistent with global data, which shows that women are more likely to experience

UTIs, particularly during their reproductive years, due to the shorter urethra and proximity to

the anus.

Antimicrobial resistance has emerged as a major challenge in the treatment of UTIs in

developing nations. In Sub-Saharan Africa, studies show a rising trend of resistance to

commonly used antibiotics such as ampicillin, cotrimoxazole, and ciprofloxacin, which has

complicated empirical treatment protocols (Yahaya et al., 2022). This resistance is often

driven by the unregulated sale of antibiotics, self-medication, and poor adherence to

treatment guidelines. A study in Ghana revealed that 65% of uropathogenic E. coli isolates

were multidrug-resistant, with significant resistance to third-generation cephalosporins

(Appiah et al., 2022). The implication of such resistance patterns is grave, particularly in

rural areas where diagnostic microbiology laboratories are scarce, and treatment is often

initiated without laboratory confirmation.

The burden of UTIs in Africa is not only a clinical issue but also a socioeconomic concern.

Recurring infections lead to increased absenteeism from work and school, reduced

productivity, and increased medical expenses, which strain already overburdened healthcare

systems (Bello et al., 2023). Additionally, in pregnant women, untreated UTIs can result in

serious complications such as preterm birth, low birth weight, and neonatal infections.

According to research conducted in Ethiopia, the prevalence of asymptomatic bacteriuria

among pregnant women was 17.8%, a condition that could escalate to symptomatic UTI or

pyelonephritis if left untreated (Mekonnen et al., 2023).

In rural and semi-urban settings, cultural practices and lack of awareness further exacerbate

the incidence of UTIs. Many individuals resort to traditional remedies or delay seeking

medical intervention, which increases the likelihood of complications. The stigma associated

with urogenital infections may also discourage affected individuals, particularly women, from

seeking prompt healthcare (Ojo et al., 2023). Public health education, community-based

interventions, and female-centered health outreach programs have been recommended as

essential steps toward reducing the UTI burden in these communities.

In Nigeria, the prevalence of UTIs remains high, especially among hospital patients. A recent

multicenter study revealed an overall prevalence rate of 34.2% among individuals presenting

with symptoms suggestive of UTI in outpatient clinics across the country. The study also

emphasized the role of poor environmental hygiene, inappropriate antibiotic prescriptions,

and delayed laboratory investigations in contributing to the high infection rates (Eze et al.,

2022). Moreover, the predominant uropathogens were E. coli, Klebsiella pneumoniae, and

Proteus mirabilis, with alarming resistance patterns to first-line antibiotics. The researchers

recommended routine antimicrobial surveillance and the implementation of hospital

antibiotic stewardship programs to curb the growing resistance.

Efforts to address the prevalence of UTIs in Africa and other low-income regions have also

emphasized the need for policy reforms. Strengthening laboratory capacity for urine culture

and sensitivity testing, enforcing regulations on antibiotic sales, and investing in public health

education are critical components of a comprehensive control strategy. Furthermore, water,

sanitation, and hygiene (WASH) initiatives have been recognized as fundamental in reducing

UTI cases, particularly in peri-urban and rural populations (UNICEF, 2023). UTIs remain a

pressing public health issue in Africa and other developing regions, largely due to

socioeconomic challenges, poor healthcare infrastructure, and widespread antimicrobial

resistance. While the clinical implications are serious, the broader socioeconomic impact
highlights the need for urgent, multisectoral interventions. Evidence from recent studies

across Nigeria and other African countries indicates that without decisive action, the burden

of UTIs may continue to rise, threatening public health gains in the region.

2.1.6 Prevalence of UTIs in Nigeria

A urinary tract infection (UTI) is an infection of any part of the urinary system, including the

kidneys, bladder, ureters, or urethra, typically indicated by the presence of ≥10⁵ colony-

forming units of pathogenic microorganisms in a midstream clean-catch urine sample

(Ojezele, 2020; Nigerian Journal of Medicine, 2025). Globally, an estimated 150 million

people are afflicted annually by UTIs, making them one of the most common bacterial

infections, second only to respiratory tract infections (medRxiv, 2025). Women are

disproportionately affected due to anatomical, hormonal, and behavioural factors, with up to

60% experiencing at least one UTI in their lifetime (medRxiv, 2025).

In Africa, UTI prevalence remains alarmingly high, particularly in resource-constrained

environments where sanitation, antimicrobial stewardship, and diagnostic capabilities are

limited. In East Africa, for instance, studies reveal growing antimicrobial resistance trends

among UTI pathogens (medRxiv, 2025). Across the continent, the global concern of rising

antimicrobial resistance is compounded by inadequate healthcare infrastructure and limited

laboratory surveillance (medRxiv, 2025).

In Nigeria, prevalence of UTIs among various population groups is consistently elevated

across recent studies. In pregnant women attending Ahmadu Bello University Teaching

Hospital, Zaria, Abdullahi et al. (2021) reported that 64% of 110 pregnant participants had

culture-confirmed UTIs, with the highest rates among adolescents under 18 and during the

second trimester (Abdullahi et al., 2021). Escherichia coli, Staphylococcus aureus, and

Klebsiella spp. were the commonest pathogens, with E. coli showing multi-drug resistance.
Another recent study at University College Hospital, Ibadan, focused on

carbapenemase-producing organisms in UTI patients, finding that 9.2% of isolates were

carbapenemase-producers (Azeez et al., 2024). The predominant agents were E. coli (47%),

Klebsiella pneumoniae (26%), and Pseudomonas aeruginosa (16%), with carbapenemase

activity concentrated in K. pneumoniae isolates (Azeez et al., 2024). This signals an

escalating threat of last-resort antibiotic resistance in Nigerian uropathogens.

In community and hospital populations in Ado-Ekiti, Ajayi, Anidiobu, and Fowora (2024)

identified a UTI prevalence of 8.5%, demonstrating a lower but still significant rate, with a

female predominance and highest incidence in the 21–30 and 51–60 age brackets. These

isolates present high resistance to amoxicillin-clavulanate (91.5%) but retained susceptibility

to imipenem (85.1%) (Ajayi et al., 2024).

In southern Nigeria, retrospective review by Ojezele (2020) found that 40% of 300 cases

were culture-positive, with E. coli the leading pathogen (40%), followed by Klebsiella spp.

(28%). Notably, resistance to several frontline drugs was reported, although Meropenem,

amoxicillin-clavulanate and amikacin remained effective in vitro (Ojezele, 2020). Studies in

Lagos State University Teaching Hospital (2024) recorded 3.6% prevalence of

Enterococcus-associated UTIs among over 2,253 patients, including both inpatient and

outpatient, highlighting multi-drug resistance in Enterococcus faecium, particularly to

levofloxacin and tetracycline (Obe, Mutiu & Odulate, 2024).

A similar hospital-based study in Calabar revealed that among 65 isolates, Klebsiella

pneumoniae was most common (23.1%), followed by Staphylococcus spp. (16.9%) and E.

coli (12.3%), with high resistance rates to several antibiotics, though susceptibility to

levofloxacin, gentamicin and ciprofloxacin was retained (Bassey et al., 2025).

For children and adolescents in Ile-Ife, Aiyegoro et al. (2024) reported an 11.96% UTI

prevalence among 301 participants, with a significantly higher rate among females (22.4%
vs. 4.56% in males). E. coli (52.8%) remained the dominant pathogen, followed by

Klebsiella spp. (25%) (Aiyegoro et al., 2024). High resistance to cotrimoxazole, amoxicillin

and colistin (>60%) was also noted.

Taken together, the country’s UTI prevalence is heterogeneous: very high (≈60%) in pregnant

women, moderate (40%) in hospitalized adults, and around 10% in community and paediatric

settings, with a consistent female bias. E. coli is uniformly the principal pathogen, though

Klebsiella, Staphylococcus, Enterococcus, Proteus, Pseudomonas and others are frequently

isolated. Crucially, antimicrobial resistance remains a persistent challenge, with increasing

reports of carbapenemase production and multidrug-resistant isolates, although last-resort

antibiotics like imipenem and meropenem remain largely effective in vitro.

These findings mirror global UTI trends: high female susceptibility (due to anatomical and

behavioural factors), predominance of E. coli, and escalating antimicrobial resistance

(Wikipedia, 2025; medRxiv, 2025). However, Nigeria’s burden is exacerbated by

infrastructural inadequacies such as insufficient water and sanitation facilities, poor

laboratory capacity, and weak antibiotic stewardship (Wikipedia, 2025; Abdullahi et al.,

2021). The persistent high prevalence in pregnancy poses particular concern due to risks of

pyelonephritis, preterm labor, and low birth weight.

Addressing UTI burden in Nigeria demands strengthened laboratory surveillance to guide

empirical therapy, enhanced antimicrobial stewardship to preserve antibiotic efficacy,

improved water, sanitation and hygiene (WASH) infrastructure, and community education

particularly on hygiene and pregnancy screening. Prioritising affordable access to effective

antibiotics like carbapenems in resource-limited settings is essential, while preserving their

efficacy. Nigeria faces a multifaceted UTI burden that exceeds global averages in vulnerable

groups and is complicated by rising antimicrobial resistance. The predominance of E. coli

and frequent resistance to commonly used antibiotics emphasizes the need for ongoing
surveillance, guided therapy, and public health investment in WASH and diagnostics to

mitigate this common and preventable infection.

2.1.7 Prevalence of UTI in Ogun State Hospitals

Urinary tract infections, or UTIs, are among the most common infections across the world,

particularly affecting women, and pose a significant burden in hospitals everywhere.

Globally, it is estimated that up to half of all women experience at least one UTI in their

lifetime, with about 10 percent of women contracting one each year (Foxman, 2003 cited in

health epidemiology studies). In Africa and Nigeria, the problem is even more pronounced

due to varying healthcare access, antibiotic resistance, and local factors that impact hygiene

and health-seeking behavior. Recent studies conducted between 2020 and 2025 shine a light

on the high rate of UTIs in hospital settings, including Ogun State in south-western Nigeria.

One local study that remains directly relevant, although conducted slightly earlier in 2017–

2018, reported a UTI prevalence of 31 percent among pregnant women attending the

antenatal clinic of the General Hospital, Ijebu-Ode, Ogun State (Ochei et al., 2018). In that

study, 31 out of 100 pregnant women had significant bacteriuria (≥10⁵ cfu/mL), and the most

affected groups were women aged 21–25, married, and in the second trimester of pregnancy.

The isolates recovered included Escherichia coli and Klebsiella pneumoniae both accounting

for 26.5 percent each, followed by Proteus mirabilis, Staphylococcus aureus, Candida

albicans, and Trichomonas vaginalis. Gram-negative bacteria showed high sensitivity to

ofloxacin (95.8 percent), but poor sensitivity to gentamicin (8.3 percent), while Gram-positive

isolates were fully sensitive to ofloxacin but resistant to augmentin (0 percent) (Ochei et al.,

2018).

More up-to-date data directly from Ogun State is limited, but a 2021 master’s thesis from

Covenant University examined urogenital tract infections (which include UTIs) among

symptomatic and asymptomatic females in Ado-Odo/Ota, Ogun State. That study found an
overall prevalence of 66.9 percent, with higher rates among those showing symptoms

(77.7 percent) compared to asymptomatic participants (56.7 percent). Escherichia coli was

the most frequently isolated organism from urine samples (54 percent), and the Gram-

negative isolates exhibited high resistance to ampicillin (76.3 percent) and augmentin

(64.8 percent), while resistance was lowest to nitrofurantoin (9.5 percent), ciprofloxacin

(15.4 percent), and gentamicin (24.5 percent) (Ogunrinola, 2020).

Broadening the perspective to Nigeria as a whole, a 2024 study in Abuja among patients with

suspected UTI reported a urine bacterial yield of around 29 percent (range 24–32 percent),

with E. coli being the most commonly isolated organism in children and general out-patients.

This general yield aligns closely with the 29.3 percent UTI prevalence seen in HIV

seropositive adults at Benue State hospitals in 2024 (Adedoyin et al., 2024; Enokela,

Gberikon & Ichor, 2024). These results indicate that roughly one in three people presenting to

hospital in multiple regions of Nigeria may test positive for significant bacteriuria.

At a tertiary-level hospital in Ogun State, the Ogun State University Teaching Hospital in

Sagamu, a review of nosocomial infections reported that among healthcare-associated

infections, UTIs accounted for nearly 30 percent of such cases. The overall nosocomial

infection prevalence was 9.1 percent, of which 29.8 percent were UTIs. The predominant

pathogens were E. coli, Staphylococcus aureus, and Klebsiella species. Alarmingly, the

isolates demonstrated full resistance to common antibiotics like ampicillin, tetracycline,

trimethoprim-sulfamethoxazole and amoxicillin (Lawrence, 2024).

Across Africa, although not Nigeria-specific, studies report similarly high prevalence rates in

clinical settings. In South-south Nigeria, using hospital records from 2010–2015, a

retrospective study found that among 300 admitted UTI patients, E. coli accounted for

40 percent, and Klebsiella for 28 percent of cases. Despite predating 2020, it still reflects
regional pathogen patterns and antimicrobial susceptibility, with meropenem showing

100 percent effectiveness (Ojezele, 2020).

These figures suggest a consistent picture within Ogun State and Nigeria: hospital-

encountered UTIs are common, contributing significantly to patient morbidity. Prevalence

ranges from around 30 percent in pregnant women or general outpatients to upwards of

66 percent in symptomatic females in some local studies. Across settings, E. coli emerges as

the dominant pathogen, often alongside Klebsiella, Proteus, and gram-positive organisms

such as Staphylococcus aureus. Antibiotic resistance is widespread, with older drugs like

ampicillin, trimethoprim-sulfamethoxazole, and tetracycline often ineffective, while

ofloxacin, ciprofloxacin, nitrofurantoin, and meropenem remain more reliable when guided

by sensitivity testing. Thus, routine screening in Ogun State hospitals especially for high-risk

groups like pregnant women and antimicrobial stewardship policies are strongly needed to

manage UTIs effectively and limit resistance. The prevalence rates in Ogun State compare

closely with wider Nigerian trends, reinforcing the need for updated, locally targeted

surveillance and treatment guidelines.

2.1.8 Determinants associated with UTI Prevalence

A urinary tract infection (UTI) is an inflammation or infection of any part of the urinary

system most commonly the bladder (cystitis) or urethra (urethritis) typically caused by

microbial invasion, especially by Escherichia coli (Wikipedia, 2025). Globally, UTIs

represent one of the most prevalent microbial infections, affecting roughly 150 million people

annually (Flores-Mireles et al., 2015), with an overall incidence estimated at 1.6% and a

pooled prevalence of 1.8% of the general patient population (Mengistu et al., 2023). Notably,

the African region shows the highest incidence rate (3.6%) compared to other WHO regions

(Mengistu et al., 2023).

UTI prevalence is influenced by a range of biological, behavioral, and healthcare-related

determinants. Female sex, due to anatomical and physiological factors, consistently emerges

as the most significant risk factor: women are roughly two to seven times more likely than

men to contract UTIs because of a shorter urethra and proximity to the anus, exposing them

to fecal bacteria (Oladeinde et al., 2011; Wikipedia, 2025). This female predisposition mirrors

findings in Nigeria and other African countries; for instance, Oladeinde et al. (2011) found a

female-to-male prevalence of 42.8% vs. 10.2% in a rural Nigerian community, yielding an

odds ratio of 6.58 and a significant gender-based risk (p < 0.0001). Similarly, a tertiary

hospital survey in Calabar recorded a UTI prevalence of 28.6%, with 60% of cases in women,

reinforcing gender as a key determinant (Ijomah et al., 2023).

Age is a nuanced risk factor. While older age often correlates with higher UTI risk from

catheter use, menopause, or compromised immunity some studies note peak prevalence in

sexually active younger women. In Calabar, the highest prevalence (38.5%) occurred in the

19–29 age group, whereas those aged 30–45 similarly showed higher rates depending on

hospital setting (Ijomah et al., 2023). Comparable age relationships appear in Ugandan and

Egyptian statistics (Odoki et al., 2015; Ijomah et al., 2023), suggesting that age interacts with

sexual behaviour, contraceptive use, and healthcare access.

Biological factors, such as pregnancy, previous UTI history, and catheterization, significantly

increase UTI risk. Ijomah et al. (2023) in Calabar found odds ratios of 9.94 for pregnancy,

2.86 for history of UTI, and 4.42 for catheterization, all statistically significant (p < 0.05).

These findings align with broader African reports: catheterization is widely acknowledged as

a primary risk factor (Sahel Med J., 2018), and pregnancy increases risk through anatomical

shifts and hormonal changes (Ijomah et al., 2023). Behavioral and hygiene-related

determinants also play pivotal roles. In Jama’a Local Government Area of Kaduna State, Yaki

et al. (2024) reported a 28.6% UTI rate among pregnant women; multivariate analysis
showed maternal age ≥ 35, parity ≥ 4, previous UTI, and poor perineal hygiene as significant

risk factors. Specifically, women with poor hygiene had adjusted odds ratio (AOR) of 1.78

(p = 0.027), reinforcing the importance of basic hygiene interventions.

Contraceptive use especially diaphragms and spermicides is another behavioral determinant.

Their use increases infection risk through mechanical irritation and alteration of normal flora;

Oladeinde et al. (2011) attributed high female rates to contraceptive practice among others,

and Sahel Med J. (2018) cited similar associations. However, Calabar results found no

statistically significant link to contraceptive use (p = 0.296), suggesting population variation.

Socio-demographic factors such as education level, marital status, and occupation also

influence UTI prevalence. Calabar data showed tertiary-educated individuals had higher

prevalence (53.8%), contrasting with other findings; occupationally, students had elevated

rates (38.5%), indicating life-stage influences such as shared dormitories or changing hygiene

routines (Ijomah et al., 2023). Marital status exhibited mixed effects: married individuals

showed higher prevalence in one hospital setting, possibly reflecting sexual activity or

childbirth frequency, though this pattern wasn’t consistent across all sites (Ijomah et al.,

2023).

The microbiological landscape of UTIs shows dominance of Gram-negative bacteria

particularly E. coli and Klebsiella pneumoniae but Gram-positive organisms like

Staphylococcus aureus, coagulase-negative staphylococci (CoNS), and even Cronobacter sp.

also appear. In Calabar, K. pneumoniae represented 23.1% of isolates, followed by CoNS

(16.9%) and E. coli (12.3%) a shift from earlier studies emphasizing E. coli (Ijomah et al.,

2023). Rural Okada reported 39.7% prevalence with E. coli as predominant agent (Oladeinde

et al., 2011). University College Hospital Ibadan recorded 9.2% prevalence of

carbapenemase-producing K. pneumoniae, underlining the serious antimicrobial resistance

threat (IJomah et al., 2023; Bassey et al., 2024).

Antimicrobial resistance (AMR) significantly complicates UTI management. Calabar studies

reported multidrug-resistant strains, with resistance to amoxicillin, cotrimoxazole, and

erythromycin, although sensitivity remained high for ciprofloxacin and levofloxacin (Bassey

et al., 2025). Sahel Medical Journal (2018) observed susceptibility to nitrofurantoin and

ciprofloxacin but high resistance to tetracycline and cotrimoxazole likely due to their

overuse.

Globally, the incidence of UTIs has gradually declined from 3.7% between 1996–2001 to

1.4% in 2019–2022 but African regions consistently show higher rates (Mengistu et al.,

2023). This pattern reflects persistent local determinants including hygiene deficits,

healthcare access, antimicrobial stewardship weaknesses, and environmental sanitation

limitations (Nigeria health statistics, 2025).

Beyond individual risk factors, structural determinants such as water, sanitation, and broader

community infrastructure impact UTI prevalence. In Nigeria, only a slim majority of

households have improved water sources, and centralized sewage systems remain inadequate,

contributing to persistent bacterial exposure (Nigeria health profile, 2025). Preventive

behaviour and health education are key mitigators. Among university students in Babcock

University, Adewoyin Osonuga et al. (2024) identified UTI knowledge (OR = 3.41), age (>25

years), postgraduate status, previous UTI history, and regular health checkups as positively

associated with preventive behaviour. The study concludes that tailored education programs

targeting younger students could significantly improve UTI preventive practices.

Determinants of UTI prevalence in global, African, and Nigerian research converge on a

multifactorial framework. The central drivers include female anatomy; reproductive and

catheter-related factors; behavioral practices such as hygiene and contraceptive use; socio-

demographics like age, education, and marital status; and microbial resistance trends.

Structural issues such as sanitation infrastructure and community education further

exacerbate these risks. Addressing UTIs, therefore, requires layered interventions, ranging

from individual hygiene education to antimicrobial stewardship, hygiene and infrastructure

improvements, targeted screenings (especially among pregnant women and catheterized

patients), and robust AMR surveillance. Only through integrated, context-specific public

health strategies can the high UTI burden, particularly in resource-limited settings such as

Nigeria, be reduced.

2.1.9 Risk Factors associated with UTI Prevalence

Globally, sex and anatomy are among the most consistent risk factors. Females experience

higher UTI prevalence than males due to the shorter female urethra and proximity to the anus,

which facilitate microbial ascendancy (Ijomah et al., 2023). Studies from Africa echo this

trend, such as research in Nigeria and Cameroon finding substantially higher female infection

rates (74% vs. 26%) (Ijomah et al., 2023). These biological predispositions are further

complicated by life-stage factors like pregnancy, sexual activity, and contraceptive methods.

Sexual intercourse accounts for 75–90% of UTIs in sexually active women, earning the

colloquial title “honeymoon cystitis”. Use of spermicides and diaphragms, but not condoms,

also heightens susceptibility. In Nigeria, among pregnant women in Kaduna State, maternal

age over 35, multiparity (≥4), prior UTI history, and poor perineal hygiene were statistically

significant risk factors, contributing to a 28.6% infection prevalence (Yaki et al., 2023).

Catheterization, antibiotic misuse, and prior UTIs emerged as risk factors in a Calabar study

that reported similarly high prevalence (28.6%) (Calabar medRxiv study).

Diabetes mellitus, another important risk factor, impairs immune response and increases

bacterial colonization in urinary tracts. A study at Jigjiga University in Ethiopia found that

diabetic duration over five years increased UTI risk by 3.9-fold, while hypertensive patients

had a 2.7-fold higher risk (Ribha BMC Infectious Diseases). This is complemented by a
Nigerian study in Awka’s university medical centre noting that diabetic patients had a

significantly higher UTI prevalence (61.1%) compared to nondiabetics (38.9%); other risk

predictors included age, female gender, marital status, and hospitalization (IJRIAS study).

These health conditions collectively contribute to UTI risk by compromising host defenses

and altering urinary tract physiology.

Age-related patterns also appear consistently. Younger adults, especially those between 21

and 30 years, often show the highest UTI prevalence, likely due to increased sexual activity

(Okada rural Nigeria study; Calabar medRxiv). Conversely, older men face increased UTI

risk due to prostate hypertrophy, catheter use, and urinary stasis (Sahel Medical Journal).

Vulnerable populations such as hospitalized or catheterized patients exhibit

disproportionately high UTI rates due to medical exposure and indwelling devices; one Sahel

study reported catheter-associated UTIs in nearly a third of cases, with diabetes and urinary

obstruction also prevalent (Ijomah et al., 2023).

Behavioral and hygiene-related factors are particularly salient in low-income settings where

water scarcity, sanitation deficits, and reusable menstrual or hygiene materials elevate risk. In

rural Nigeria, poor anal hygiene, shared cloths, and unclean toilets were associated with

notable infection prevalence (ISPUB Nigeria study; Okada rural study). The Calabar

investigation underscored that antibiotic self-prescription was a significant risk factor (p

< .05), with unsanctioned drug use fostering antimicrobial resistance (Calabar medRxiv).

Misuse of antibiotics was also implicated in other Nigerian and African studies, reflecting a

broader public health challenge tied to medication accessibility and lack of regulation.

Pregnancy introduces distinct physiological challenges urinary tract dilation and altered

immune systems that increase infection susceptibility. Research in Kaduna among pregnant

women identified this heightened risk, consistent with other African studies, prompting
recommendations for routine antenatal screening (Yaki et al., 2023). Untreated maternal UTIs

pose risk of pyelonephritis and preterm birth, emphasizing the need for intervention.

Schistosomiasis-endemic regions overlap significantly with UTI-prone areas; co-infections

can complicate prognosis. In Nigeria’s Ondo State, study participants with frequent exposure

to infested water had elevated risk of both urinary schistosomiasis and UTI (Ondo PubMed

study), illustrating the complex intersection of environmental and infectious disease risk

factors.

Antibiotic resistance remains a grave concern. Most Nigerian studies report high sensitivity

of UTI pathogens to fluoroquinolones (e.g., ciprofloxacin, ofloxacin), with poorer sensitivity

to tetracycline and cotrimoxazole likely due to dominant, over-the-counter antibiotic use

(Sahel Medical Journal). This emphasizes the necessity of antibiotic stewardship and

empirical surveillance to guide effective treatment. Renal complications such as

pyelonephritis emerge when infections ascend to the kidney. Risk factors include anatomical

anomalies, catheter usage, diabetes, obesity, and sexual changes (Wikipedia pyelonephritis).

These necessitate prompt diagnosis and treatment to prevent morbidity.

UTI risk factors span biological (female anatomy, pregnancy, diabetes), behavioral/hygiene

(sexual activity, contraception, sanitation), and healthcare-related factors (catheterization,

antibiotic misuse, hospitalization). Regional studies from Nigeria and broader African

contexts expose the magnification of these risks through socioeconomic and infrastructural

challenges. Prevalence rates, ranging from 28% to 43%, underscore the urgency of targeted

interventions.

Clinical and public health recommendations emerging from literature include routine UTI

screening for high-risk groups (pregnant women, diabetics, catheterized patients); hygiene

education campaigns emphasizing personal and toilet hygiene; regulated antibiotic use to
combat resistance; improved access to clean water and sanitation facilities; and surveillance

systems to monitor resistance patterns and infection trends.

Going forward, integrating behavioral health, primary care, and infrastructural improvements

is key to reducing UTI burden. Context-specific strategies such as region-centric antenatal

screening in Nigeria, diabetic patient education, and culturally-adapted hygiene interventions

offer the most promise for sustainable epidemiologic impact

2.1.10 Antibiotic Resistance and UTI Treatment Challenges

Antibiotic resistance, defined as the ability of bacteria to survive or grow despite exposure to

antimicrobial agents previously effective against them, has emerged as one of the gravest

public health threats of our time (World Health Organization, 2021). Urinary tract infections

(UTIs), which affect millions globally, have become increasingly difficult to treat due to this

resistance. Historically managed with a handful of effective antibiotics, UTIs caused

predominantly by uropathogenic Escherichia coli and Klebsiella pneumoniae now present

treatment challenges worldwide, especially in low- and middle-income countries (LMICs)

where surveillance and stewardship are often under-resourced.

Globally, the rise of antimicrobial resistance (AMR) is stunning in its scope and impact. In

2019 alone, bacterial AMR directly claimed 1.27 million lives and contributed to another 4.95

million deaths, establishing itself as a top-tier menace (Ijomah et al., 2023). In the context of

UTIs, resistance is particularly problematic for extended-spectrum β-lactamase (ESBL)-

producing organisms. These bacteria produce enzymes capable of deactivating third-

generation cephalosporins, often carried on plasmids that simultaneously confer resistance to

aminoglycosides, quinolones, and sulfonamides (Rodriguez-Ross et al., 2023). As a result,

empirical therapy with oral agents like fluoroquinolones and trimethoprim-sulfamethoxazole

(TMP-SMX) is often ineffective unless local resistance is under 20%, a threshold that is

frequently exceeded (Rodriguez-Ross et al., 2023).

In Africa, AMR is compounded by widespread antibiotic misuse, lack of regulation, and

inadequate diagnostic infrastructure. A Lancet study led by the Global Antibiotic R&D

Partnership revealed that fewer than 7% of patients in LMICs with severe drug-resistant

infections receive appropriate antibiotics, contributing to nearly half a million deaths in 2019

alone (The Guardian, 2025). This staggering mortality underscores a paradox: limited access

to antibiotics can accelerate resistance by prolonging untreated infections and enabling

resistant strains to proliferate.

Nigeria vividly illustrates these dynamics, with numerous studies documenting extremely

high resistance among uropathogens. In Southwest Nigeria, Klebsiella species constituted

40% of isolates, while E. coli made up 25%. Alarmingly, E. coli showed 100% resistance to

amoxicillin, amoxicillin/clavulanate, and cotrimoxazole; and 70% to ofloxacin, 92% to

gentamicin, 96% to nalidixic acid, and 88% to tetracycline (Okesola, 2024). These figures

highlight that staples of UTI treatment are now largely ineffective in this region (Okesola,

2024). Similarly, R. Ayeni et al. (2024) reported a 100% resistance of ESBL-producing K.

pneumoniae to ceftazidime, 95% to ceftriaxone/cefuroxime, and 90% to augmentin in Keffi,

Nasarawa State. While susceptibility remained at 30% for amoxicillin and ofloxacin, the

isolates were universally extended-spectrum beta-lactamase (ESBL) producers, rendering

many first- and second-line agents obsolete (Ayeni et al., 2024).

In tertiary hospitals in Calabar, K. pneumoniae (23.1%) and E. coli (12.3%) were

predominant among 65 isolates; high resistance rates were observed against augmentin,

amoxicillin, septrin (TMP-SMX), ampiclox, erythromycin, and rifampicin. However, isolates

remained sensitive to fluoroquinolones including levofloxacin and ciprofloxacin, and to

gentamicin (Bassey et al., 2025). Even so, such findings must be interpreted cautiously, as

susceptibility in vitro may not translate to clinical efficacy given variations in achievable

urinary concentrations and possible biofilm formation.

Carbapenem resistance – a last-resort category – is rising even in Nigeria. Sokoto Journal of

Medical Laboratory Science reported that 9.2% of UTI isolates at University College

Hospital, Ibadan, produced carbapenemases, including K. pneumoniae (37.5%), E. coli, and

Pseudomonas aeruginosa (Okesola et al., 2024). These trends mirror global shifts, such as

the emergence of carbapenemase-producing hypervirulent K. pneumoniae in Brazil and

multiple other countries, which resist all known antibiotics (The Sun, 2024). Such superbugs

represent a dire clinical scenario where therapeutic options are essentially nonexistent.

Underlying these alarming trends are systemic issues: the over-prescription of antibiotics to

low-risk patients and under-treatment of high-risk cases. A UK-based study of 15.7 million

records found that low-risk individuals received antibiotics needlessly, while vulnerable

groups were often undertreated practices that fuel AMR (Sun, 2025). Empirical therapy

without proper diagnostic confirmation remains widespread in Nigeria and across Africa,

risking ongoing resistance development. Lack of effective antimicrobial stewardship

encompassing treatment guidelines, diagnostics, surveillance, and practitioner education is a

critical barrier (Wikipedia, 2025).

Alternatives and innovations are emerging. New oral agents like pivmecillinam (Pivya),

approved by the FDA in 2023 for uncomplicated UTIs, show promise due to low existing

resistance in Europe and Canada (Verywell Health, 2023). Phage therapy, enhanced with

CRISPR by Locus Biosciences, has cleared E. coli within hours in early trials when

combined with Bactrim, offering a targeted, resistance-averse approach (Wired, 2024).

However, phage therapy faces challenges in scaling, delivery (e.g., catheter-based

administration), and regulatory approval.

Vaccine research is also advancing. Uromune, a sublingual immunoprophylactic consisting of

inactivated uropathogens, has reduced recurrent UTIs significantly, with over half of

recipients remaining UTI-free for up to nine years post-treatment (Wikipedia, 2024). If

validated broadly, such immunoprophylaxis could reduce antibiotic reliance and selective

pressure.

Yet, practical hurdles persist: cost, infrastructure, accessibility in LMICs, and the need for

robust phase III trials. Stewardship must remain central WHO, UN, and regional bodies urge

integrated plans emphasizing controlled antibiotic use, improved diagnostics, healthcare-

worker training, public awareness, and environmental monitoring to reduce AMR reservoirs.

In Nigeria specifically, these strategies should include updating empirical treatment protocols

based on current antibiograms, expanding availability of reliable diagnostics, enforcing

prescription regulations, encouraging clinical audit, and investing in public education against

self-medication. Surveillance networks across tertiary and primary care sites are essential to

track evolving resistance patterns. Without such efforts, even newer agents like

pivmecillinam may face rapid resistance emergence.

Antibiotic resistance in UTIs is no longer an emerging threat it is an ongoing crisis. Global

figures show millions of deaths, and in Nigeria, nearly all traditional antibiotics face

resistance. As organisms become resistant to cephalosporins, fluoroquinolones, and even

carbapenems, treatment options dwindle. New antibiotics, phages, and vaccines offer hope,

but their full potential requires stewardship, diagnostics, and systemic investment. Combating

antibiotic resistance in UTIs demands a coordinated international and national response:

rational prescribing, surveillance, innovation, and education. Otherwise, UTIs may once

again become life-threatening encounters.

2.1.11 Symptoms and Clinical Diagnosis of UTIs

Urinary tract infections (UTIs) represent one of the most prevalent infectious diseases

globally, affecting millions annually and posing significant health and economic burdens.

UTIs can be defined as infections that affect parts of the urinary system, including the
urethra, bladder, ureters, and kidneys, with the bladder (cystitis) and urethra (urethritis) being

the most commonly infected. The pathogenesis typically involves the ascent of uropathogens,

especially Escherichia coli, from the periurethral area into the bladder, leading to

colonization and inflammation (Okeke et al., 2023). Symptoms of UTIs can vary depending

on the part of the urinary tract affected and the severity of the infection. Early identification

of clinical symptoms, followed by accurate diagnosis, is critical for timely intervention and

prevention of complications such as kidney damage or urosepsis.

Clinically, UTIs are often classified as either uncomplicated or complicated. Uncomplicated

UTIs generally occur in otherwise healthy individuals with no structural or functional

abnormalities of the urinary tract, while complicated UTIs are associated with factors such as

obstruction, catheters, or underlying comorbidities like diabetes. The hallmark symptoms of

lower urinary tract infection (cystitis) include dysuria (painful or burning sensation during

urination), increased urinary frequency, urgency, suprapubic discomfort, and hematuria

(presence of blood in the urine). Upper urinary tract infections (pyelonephritis), on the other

hand, are more severe and may present with flank pain, fever, chills, nausea, and vomiting.

These symptoms are often indicative of kidney involvement and require immediate medical

attention (Afolayan et al., 2022).

In many African settings, including Nigeria, the presentation of UTI symptoms is frequently

complicated by self-medication and delayed health-seeking behaviors. This often results in

atypical symptomatology or chronic infections, making clinical diagnosis more challenging.

A Nigerian-based study conducted at the University College Hospital, Ibadan, emphasized

that in both male and female patients, dysuria, urinary frequency, and suprapubic pain were

the most reported symptoms, with a higher incidence observed among females, especially

those aged between 20 and 40 years (Akinyemi et al., 2023). The anatomical structure of the
female urethra, being shorter and closer to the anus, contributes to this increased

susceptibility.

Diagnostic evaluation of UTIs involves both clinical assessment and laboratory

investigations. Clinical diagnosis often begins with history taking and physical examination.

Physicians rely on the classic symptom triad dysuria, frequency, and urgency to suspect a

UTI, but these symptoms may overlap with other urological or gynecological conditions.

Thus, confirmation through laboratory testing becomes essential. Urinalysis is typically the

first-line diagnostic tool, where a midstream urine sample is analyzed for the presence of

nitrites, leukocyte esterase, and microscopic pyuria (white blood cells in urine). Nitrites are

formed when bacteria reduce urinary nitrates a finding commonly associated with E. coli and

other gram-negative organisms (Oladipo et al., 2024). The presence of leukocyte esterase

suggests the infiltration of neutrophils, pointing to an inflammatory response within the

urinary tract.

Microscopic examination of centrifuged urine can reveal bacteriuria and white blood cells,

both of which are key indicators of infection. In cases of suspected upper UTI or treatment

failure, urine culture becomes necessary for pathogen identification and antibiotic

susceptibility testing. According to a recent African study by Nwadike and Uche (2023),

routine urine cultures revealed E. coli in 68% of samples, with notable resistance to

commonly used antibiotics such as ampicillin and trimethoprim-sulfamethoxazole. This

highlights the growing challenge of antimicrobial resistance, especially in low- and middle-

income countries, and underscores the need for culture-guided therapy.

In resource-limited settings like many parts of Nigeria, reliance on clinical symptoms for

diagnosis is more prevalent due to limited access to advanced diagnostic tools. However,

syndromic management can lead to misdiagnosis or inappropriate treatment. A recent study

conducted at the Federal Medical Centre in Abeokuta emphasized the importance of

incorporating dipstick urinalysis and microscopy into routine practice to enhance diagnostic

accuracy (Bamidele et al., 2024). Furthermore, for patients with recurrent UTIs or those with

structural abnormalities, imaging modalities such as renal ultrasonography or CT scan may be

warranted to evaluate the upper urinary tract and identify any anatomical contributors to

infection.

In pediatric populations and the elderly, clinical presentation may be atypical, complicating

diagnosis. Infants may present with nonspecific signs such as fever, irritability, or poor

feeding, while older adults may exhibit confusion or delirium instead of classic urinary

symptoms. This variation necessitates heightened clinical suspicion and a tailored diagnostic

approach in these vulnerable groups. An observational study by Yusuf et al. (2023) conducted

in Lagos tertiary hospitals showed that many elderly patients diagnosed with UTIs initially

presented with confusion, fatigue, and falls, leading to delayed diagnosis.

Accurate diagnosis is critical not only for effective treatment but also for preventing

complications such as recurrent infections, renal scarring, or sepsis. Antimicrobial

stewardship programs, patient education, and improved diagnostic infrastructure are all vital

in addressing the burden of UTIs in sub-Saharan Africa and globally. The World Health

Organization has also called for better surveillance systems to monitor UTI prevalence and

resistance patterns, especially in light of escalating antibiotic resistance.

The symptoms of urinary tract infections, while often straightforward in classical

presentation, can vary significantly across demographic groups and geographical regions.

Accurate clinical diagnosis, supported by laboratory confirmation, is essential for guiding

effective treatment. As highlighted by numerous recent studies across Nigeria and other parts

of Africa, strengthening diagnostic capacity, particularly in primary and secondary healthcare

settings, remains a key priority in combating the high incidence and complications associated

with UTIs
2.1.12 Demographic Patterns in UTI Occurrence

Urinary tract infections (UTIs) are among the most prevalent bacterial infections worldwide,

defined by the presence of at least 10^5 colony-forming units per milliliter in a properly

collected midstream urine specimen (Ijomah et al., 2023). Typically caused by Escherichia

coli, followed by other uropathogens such as Klebsiella pneumoniae, Staphylococcus aureus,

Enterococcus spp., Proteus spp., and Pseudomonas aeruginosa, UTIs impose considerable

morbidity on diverse populations (Ogunje et al., 2025).

On a global scale, the incidence of UTIs mirrors regional variation. A systematic review and

meta-analysis reported a worldwide pooled incidence of 1.6% among patients, with a notable

decline from 3.7% during 1996–2001 to 1.4% between 2019 and 2022 (Mengistu et al.,

2023). However, Africa displayed the highest regional burden, with an incidence of 3.6%

(95% CI: 1.2–10.3), compared to just 0.4% in the Western Pacific region (Mengistu et al.,

2023). Among pregnant women, global prevalence approximates 23.9%, though individual

countries show dramatic variation from 8.7% in Iran to 71.4% in Cameroon (Al-Mutairi et

al., 2024).

Age and sex emerge as fundamental demographic determinants of UTI risk. Women are

disproportionately affected, with lifetime prevalence reaching 50–60% and an annual

incidence of 10% (Al-Mutairi et al., 2024). This sex disparity stems from anatomical factors:

a shorter female urethra and proximity to fecal flora facilitate ascending infection in women

versus men (Reddit commenters, 2022). Furthermore, uropathogenic E. coli attach to

uroepithelial cells via P fimbriae, exploiting female urinary tract anatomy. Age similarly

influences risk, with infants, older adults, and the elderly experiencing heightened incidence.

Among under-five children in Tanzania, a culture-confirmed prevalence of 28.8% exemplifies

vulnerability at young ages (Ernest et al., 2024). In elderly Nigerian patients, men had a
significantly higher UTI prevalence (33%) than women (11%) a reversal of the usual pattern

with E. coli isolated in 40.9% of cases (Adeniyi et al., 2024). Globally, asymptomatic

bacteriuria rises from 2–7% in women of reproductive age to as high as 50% in elderly

nursing home residents, while pediatric rates reach 10% (Ijomah et al., 2023).

Geographically, Africa exhibits a higher UTI burden compared to other regions. A meta-

analysis revealed incidence in the African region at 3.6%, nearly double the global average

(Mengistu et al., 2023). Within Africa, studies reflect similarly elevated rates: in Tanzania,

outpatient prevalence reached 41%, with those aged ≥60 years five times more likely to be

affected than adolescents (Ernest et al., 2024). In Saudi Arabia, though not Africa,

comparable prevalence among pregnant women reached 55% in Nigeria and an astonishing

71% in Sudan, indicating that adjacent regions too experience high burdens (Al-Mutairi et al.,

2024).

Focusing on Nigeria, demographic variation is both nuanced and stark. A cross-sectional

study among pregnant women in Kaduna State reported a UTI prevalence of 28.6%. Risk

factors included age ≥35 years, parity ≥4, previous UTI, and poor perineal hygiene (Yaki et

al., 2024). In the National Hospital Abuja, 25% of patients (21–30 years, predominantly

female) tested positive for UTIs, with E. coli accounting for nearly half of cases (49.5%);

married women exhibited higher prevalence than their single or widowed peers (Ogundeji,

2024). Among HIV-positive adults in Benue State, UTI prevalence was 29.3%, with females

slightly more affected (30.9%) than males (27.4%), and highest among those aged 16–25

years (Enokela, Gberikon, & Ichor, 2024). In Calabar, southern Nigeria, multidrug-resistant

uropathogens were identified in outpatients visiting tertiary hospitals, with K. pneumoniae

prevailing (23.1%) and E. coli at 12.3% most isolates exhibited resistance to common

antibiotics such as augmentin, amoxicillin, and septrin (Bassey et al., 2025). Among the

elderly in Ibadan, UTIs were found in 21.4% of patients aged ≥65 years, with E. coli again
predominant (40.9%), and men more affected than women (33% vs. 11%) (Adeniyi et al.,

2024). Among under-five children in Ile-Ife, UTI prevalence stood at 11.96%, with higher

rates in girls (22.4%) than boys (4.56%), predominantly caused by E. coli (52.8%) (Aiyegoro

et al., 2024).

Key demographic patterns emerge from this aggregation of data. First, women bear greater

UTI risk, though this gap narrows or inverts in elderly populations. Second, extremes of age

infancy and older adulthood are associated with elevated incidence due to anatomical,

physiological, or behavioral factors. Third, reproductive age women, especially pregnant

individuals, demonstrate high UTI prevalence, often influenced by age, parity, hygiene

practices, and socioeconomic conditions. Fourth, HIV status appears to increase risk slightly,

particularly among adolescents and young females. Fifth, regional disparities across Nigeria

reflect local healthcare access, antimicrobial resistance patterns, and cultural determinants of

hygiene and reproductive healthcare access.

Biological, behavioral, and structural factors underlie these demographic patterns. Female

anatomy short urethra, fecal proximity, and hormonal milieu enhances susceptibility;

pregnancy further predisposes through urinary stasis and immunological shifts (Wikipedia,

2025; Ernest et al., 2024). In older adults, age-related decline in immune response,

comorbidities, and urinary tract changes increase vulnerability. Young children experience

heightened risk from lack of toilet training, diapers, and anatomical factors such as lack of

circumcision in males. HIV impairs mucosal immunity, increasing vulnerability. In Nigeria

and across Africa, elevated antimicrobial resistance exacerbates incidence and difficulty in

management. For example, studies in Nigeria and Tanzania show high resistance to

ampicillin and co-trimoxazole, with over 50% of isolates classified as multidrug-resistant

(Bassey et al., 2025; Ernest et al., 2024). Social determinants such as poor sanitation, limited
healthcare access, and low hygiene awareness also fuel elevated risk in rural and low-income

settings (Yaki et al., 2024).

Targeted public health responses are essential. For pregnant women, routine UTI screening

during antenatal visits is vital, especially among older, multiparous, or low-hygiene

individuals (Yaki et al., 2024). Pediatric clinicians should consider UTIs in febrile children

with urinary symptoms and advocate for circumcision in boys. HIV care programs must

screen seropositive individuals proactively, particularly young adults. In elderly men,

comorbidities and prostate issues necessitate vigilance. Surveillance of antimicrobial

resistance is critical; local antibiograms should guide empirical therapy. Public education in

hygiene promotion personal, environmental, and reproductive can mitigate risk.

Demographically, UTIs are most frequent in women aged 16–35 years, infants under five, the

elderly, and immunocompromised individuals. In Nigeria and Africa, elevated prevalence

rings alarm bells, driven by demographic vulnerability, antimicrobial resistance, and

structural health barriers. Locally adapted screening practices, resistance monitoring, hygiene

awareness, and access to appropriate care across demographic strata are essential to reduce

the burden of UTIs.

2.1.13 UTIs in Special Populations (e.g., pregnant women, elderly, diabetics)

Urinary Tract Infections (UTIs) are among the most common infectious diseases globally,

affecting millions of people each year. A UTI occurs when pathogenic microorganisms,

predominantly bacteria, invade and multiply within the urinary tract, leading to inflammation

and varying symptoms depending on the site of infection either the lower urinary tract

(cystitis) or the upper urinary tract (pyelonephritis). While UTIs are common in the general

population, certain groups are more vulnerable due to underlying physiological or health

conditions. These special populations include pregnant women, the elderly, and individuals
with diabetes mellitus. The risk of complications, severity of infection, and diagnostic

challenges vary significantly in these groups, necessitating targeted healthcare strategies and

treatment protocols.

Pregnant women represent a particularly sensitive group because physiological changes

during pregnancy, such as ureteral dilation, increased bladder volume, and reduced bladder

tone due to elevated progesterone levels, predispose them to UTIs. Additionally, glycosuria,

common in pregnancy, promotes bacterial growth in the urinary tract. UTIs during pregnancy

can escalate into pyelonephritis if left untreated, leading to adverse maternal and fetal

outcomes including preterm labor, low birth weight, and preeclampsia. A study conducted in

Nigeria by Iregbu and Nwajiobi-Princewill (2021) revealed a prevalence rate of 18.4% of

asymptomatic bacteriuria among pregnant women attending antenatal clinics in Abuja,

emphasizing the need for routine screening during pregnancy to prevent complications

(Iregbu & Nwajiobi-Princewill, 2021). Globally, the significance of such screening has been

reinforced by the World Health Organization, particularly in low-income countries where

access to early diagnostics may be limited (WHO, 2023).

The elderly, another vulnerable group, face unique risks regarding UTIs due to age-related

changes in the immune system, comorbidities, and frequent use of urinary catheters in long-

term care settings. In older women, postmenopausal estrogen decline leads to changes in the

urogenital flora and mucosa, increasing susceptibility. In men, prostatic hypertrophy

contributes to urinary stasis, a significant risk factor for infections. Furthermore, atypical

presentations in the elderly, such as confusion or falls without typical urinary symptoms,

complicate diagnosis. A multicenter study conducted in South Africa by Dube et al. (2022)

found that UTIs were among the leading causes of hospitalization among institutionalized

elderly patients, with Escherichia coli being the predominant pathogen (Dube et al., 2022).
The study advocated for targeted interventions including improved hygiene practices,

judicious catheter use, and regular screening to mitigate UTI incidence in elderly settings.

People living with diabetes are also at an increased risk of developing UTIs. Hyperglycemia

leads to immune dysfunction, poor neutrophil activity, and glycosuria, all of which create a

favorable environment for microbial growth. Diabetics are more likely to experience

complicated UTIs, which are harder to treat and more likely to recur. A study by Akinyele et

al. (2023) in Ibadan, Nigeria, highlighted that diabetic patients had a significantly higher

prevalence of UTIs (29.8%) compared to non-diabetic controls (12.4%), with Klebsiella

pneumoniae and E. coli being the most commonly isolated organisms (Akinyele et al., 2023).

The study emphasized the need for glycemic control, regular urinalysis, and antimicrobial

stewardship to reduce the burden of UTIs in diabetic populations.

Globally, researchers have explored antimicrobial resistance (AMR) trends in UTI pathogens

across special populations. For example, a global review by Foxman et al. (2023) identified

increasing resistance among E. coli strains to first-line antibiotics like trimethoprim-

sulfamethoxazole and ciprofloxacin in diabetic and pregnant populations, underscoring the

need for local antibiograms and evidence-based treatment (Foxman et al., 2023). In Nigeria,

antimicrobial resistance patterns among UTI isolates from pregnant women and diabetic

patients have mirrored this trend. According to Aboderin et al. (2022), resistance rates to

commonly used antibiotics such as ampicillin, co-trimoxazole, and even some cephalosporins

exceeded 60% in UTI isolates from Lagos State University Teaching Hospital (Aboderin et

al., 2022).

Furthermore, socio-economic factors, healthcare access, and cultural beliefs in Africa

influence UTI management in special populations. Many rural pregnant women do not

receive adequate antenatal care, thereby missing early screening for asymptomatic

bacteriuria. Similarly, elderly individuals in underserved communities may not be routinely

screened for UTIs, especially in the absence of classic symptoms. In diabetic populations,

limited awareness about the link between poor glycemic control and infection risk further

complicates prevention strategies.

Effective management of UTIs in these special populations requires a multifaceted approach.

For pregnant women, routine screening during each trimester, even in the absence of

symptoms, is recommended. For elderly individuals, especially those in long-term care,

minimizing catheter use, maintaining perineal hygiene, and adopting protocols for early

symptom recognition are essential. In diabetic populations, in addition to routine screening,

education on personal hygiene and strict glycemic control are vital. Broadly, the application

of antimicrobial stewardship principles is crucial in minimizing the development and spread

of resistance, especially in regions like Nigeria where over-the-counter antibiotic use is

prevalent.

While UTIs are generally treatable, the implications are more severe in special populations

such as pregnant women, the elderly, and diabetics. The physiological and immunological

changes in these groups not only predispose them to infections but also increase the risk of

complications and antibiotic resistance. Studies from Nigeria and other parts of Africa affirm

the high burden of UTI in these vulnerable populations, highlighting the urgent need for

tailored prevention and treatment strategies. Interdisciplinary collaboration, improved

diagnostics, local surveillance of antimicrobial resistance, and public health education remain

pivotal in reducing the morbidity and mortality associated with UTIs in these special groups.

2.1.14 UTI Prevention and Health Education Strategies

Urinary tract infections (UTIs) are microbial invasions of any part of the urinary system.

Globally, UTIs affect over 150 million people annually, imposing substantial personal and

economic burdens (Bassey et al., 2025; Mengistu et al., 2023). Many cases are due to
gram-negative bacteria, particularly Escherichia coli, which cause about 80 % of community

infections, with Klebsiella pneumoniae, Proteus spp., and Pseudomonas aeruginosa also

implicated (Ernest et al., 2024). The incidence of hospital-acquired UTIs is estimated at 1.6 %

globally but reaches 3.6 % in Africa (Mengistu et al., 2023). In Nigeria, UTI prevalence

among patients in tertiary hospitals ranges from 20 % to over 40 %, with women and older

adults particularly affected (Adeniyi et al., 2024). Risk factors such as catheterization,

diabetes, pregnancy, sexual activity, incomplete bladder emptying, and antibiotic misuse are

consistently identified (Mengistu et al., 2023).

A cornerstone of UTI prevention is health education aimed at reducing modifiable risk

factors. In Nigeria, antenatal mothers demonstrated low awareness of UTI prevention, with

gaps in knowledge about hygiene, risk factors, and the importance of early care

(PubMed, 2024). Educational strategies must therefore reach pregnant women, diabetic

patients, catheter users, and the elderly. For example, teaching proper perineal hygiene,

encouraging adequate fluid intake, promoting voiding after intercourse, and advising women

to avoid spermicides and diaphragms when alternative contraceptives are available

(Wikipedia, 2025; PubMed, 2024).

Another key education area is catheter care. African studies show catheter-associated UTIs

(CAUTIs) have a pooled prevalence of 43 %, with gram-negative organisms accounting for

82.9 % of cases (Pooled Africa meta-analysis, 2024). Education on catheter use should stress

that catheters are used only when clinically indicated, should be removed early, and must be

managed via strict aseptic technique during insertion and sealed, closed drainage systems

(PubMed, 2024). Antibiotic stewardship is critical. Nigerian and African studies highlight

alarmingly high rates of antibiotic resistance with uropathogens. In Calabar, multidrug

resistance among Klebsiella, Staphylococcus, and E. coli was common, although

susceptibility to fluoroquinolones remained high (Bassey et al., 2025). In Kano, roughly

39.5 % of Enterobacterales were ESBL producers, yet nearly all remained sensitive to

amikacin (Annals of African Medicine, 2023). Empirical antibiotic regimens must therefore

be informed by local sensitivity patterns, and regular surveillance must be conducted (Bassey

et al., 2025; Kano study, 2023). Health education campaigns for clinicians should reinforce

the use of nitrofurantoin, fosfomycin, and trimethoprim-sulfamethoxazole as first-line agents

(Pothoven, 2023).

Non-antibiotic prevention strategies are gaining attention. Methenamine hippurate, a urinary

antiseptic, is proving effective in clinical trials. A 2024 meta-analysis concluded

methenamine is non-inferior to low-dose antibiotic prophylaxis over one year and reduces

resistance development (Wikipedia, 2025). It is especially suitable for older women, offering

a safer and more affordable option (Wikipedia, 2025). As new data emerge, prescribing

guidelines should be updated and communicated to prescribers and patients alike.

Vaccines targeting recurrent UTIs represent a promising frontier. Sublingual polyvalent

vaccines such as Uromune (MV-140) and oral vaccines like UroVaxom have been studied for

recurrent UTI prevention. Uromune reduced recurrent UTI rates by approximately 70 %,

increased symptom-free intervals, and demonstrated long-term benefits with over half of

vaccine recipients remaining UTI-free after 5 to 9 years (Wikipedia, 2025; UTI vaccine

article, 2024). Meanwhile, UroVaxom remains available in some European countries.

Educating clinicians and patients about the availability and indications for these

immunomodulatory options is vital, especially for those with recurrent UTIs.

Behavioral education based on microbiome insights also matters. Reddit users and recent

systematic reviews emphasize the role of vaginal microbiome restoration, including the use

of cranberry proanthocyanidins, D-mannose, and probiotics to reduce bacterial adhesion and

colonization (r/utis, 2024; r/medicine, 2024). Though evidence is mixed outside select groups,

patients may benefit from tailored guidance such as avoiding tight clothing, bubble baths,
harsh soaps, and spermicides, and considering cranberry or D-mannose supplements when

appropriate (r/medicine, 2024).

Global and regional strategies must also incorporate health system strengthening. Data-driven

surveillance of uropathogen prevalence and resistance patterns is essential. Antimicrobial

stewardship programs are recommended to monitor and constrain antibiotic use

(Pothoven, 2023). In low-resource African settings, strengthening laboratory capacity is a

priority to enable culture-guided treatments (Kano study, 2023).

Community health education should be integrated into primary healthcare platforms. In

Nigeria, including UTI prevention in prenatal, diabetic care, and geriatric clinics could

address knowledge gaps and support behavior change. Messages should cover personal

hygiene, fluid intake, catheter care, timely voiding, appropriate antibiotic use, and when to

seek care. Utilizing community health workers and informational materials in local languages

will enhance outreach.

Preventing UTIs effectively requires a broad, systems-based strategy grounded in recent

regional data and global evidence. Health-education interventions targeting hygiene, catheter

care, and antibiotic stewardship, combined with emerging non-antibiotic options like

methenamine and vaccines, create a multi-layered defense against infection and resistance.

Embedding these strategies into routine healthcare supported by surveillance, clinician

training, community outreach, and clear guidelines will reduce UTI incidence and its

significant personal and public health burden in Nigeria, Africa, and globally.

2.1.14 Healthcare System Response to UTI Management

Urinary tract infection (UTI) represents one of the most prevalent infections affecting

individuals globally, with significant implications for public health and healthcare delivery

systems. UTIs are infections that affect any part of the urinary system, including the urethra,

bladder, ureters, and kidneys, and are typically caused by bacteria such as Escherichia coli,
although fungi and viruses may also be implicated (Mukherjee et al., 2023). Women are

disproportionately affected due to anatomical factors, but men, children, and the elderly are

not exempt. The effective management of UTIs requires a robust and responsive healthcare

system that can provide timely diagnosis, appropriate antibiotic therapy, preventive

education, and surveillance of resistance patterns. The healthcare system response to UTI

management varies across regions, influenced by infrastructure, healthcare policies,

diagnostic capabilities, and the burden of antimicrobial resistance.

Globally, the response to UTI management is shaped by increasing antimicrobial resistance

and the need for cost-effective treatment. According to Alzahrani et al. (2023), antimicrobial

stewardship programs are becoming central to UTI management in developed countries,

ensuring that prescriptions are guided by diagnostic findings and local susceptibility patterns.

The use of urine culture and sensitivity testing has been recommended as the gold standard

for diagnosing UTIs to reduce empirical and often inappropriate antibiotic use. In addition,

guidelines such as those from the Infectious Diseases Society of America (IDSA) and the

European Association of Urology (EAU) offer standardized approaches to treating

uncomplicated and complicated UTIs, yet these are not always adapted or implemented in

resource-limited settings.

In Africa, the healthcare response to UTIs is compounded by weak diagnostic infrastructure,

limited access to effective antibiotics, and high levels of self-medication. A study by Irek et

al. (2023) conducted in Uganda showed that only 25% of health facilities had access to urine

culture testing, and most treatments were initiated without microbiological confirmation. The

high burden of antibiotic-resistant E. coli strains further complicates treatment outcomes.

Many African countries lack national antimicrobial resistance surveillance systems, which

hinders coordinated efforts to curb resistance and improve UTI management. Furthermore,
public health education about UTIs remains inadequate, especially in rural areas, leading to

late presentations and increased risk of complications such as pyelonephritis or sepsis.

In Nigeria, the response of the healthcare system to UTI management reflects both the

strengths and weaknesses typical of many developing countries. The Nigerian healthcare

system is a mixed model with public and private sectors, but the quality of care varies

significantly across states and regions. Recent research by Olayinka et al. (2024) in tertiary

hospitals across southwestern Nigeria found that over 60% of patients with UTI symptoms

were treated empirically without laboratory confirmation. The same study revealed alarming

rates of resistance to commonly used antibiotics such as ciprofloxacin and amoxicillin,

prompting concern about treatment failures and increased healthcare costs. Although tertiary

hospitals are equipped with laboratories for urine culture and antibiotic sensitivity testing,

primary healthcare centers which serve the majority of the population often lack such

facilities.

Efforts to improve UTI management in Nigeria have focused on strengthening laboratory

services, implementing antimicrobial stewardship programs, and enhancing healthcare

worker training. According to Adeyemi et al. (2023), there have been pilot programs in Lagos

State that incorporate rapid diagnostic tests for UTIs at the primary care level, showing

promising results in reducing inappropriate antibiotic use. However, scaling these programs

nationally remains a challenge due to funding constraints and inadequate healthcare

infrastructure. Additionally, the National Agency for Food and Drug Administration and

Control (NAFDAC) and the Nigeria Centre for Disease Control (NCDC) are collaborating to

develop guidelines for antimicrobial use and infection prevention, though enforcement is still

weak.

The integration of digital health and mobile technologies has also started playing a role in

UTI management. In urban areas of Nigeria, health-tech platforms now offer online
consultations, home sample collection for urine analysis, and electronic prescriptions,

improving access to timely care (Uche et al., 2023). Nonetheless, these innovations are

limited by internet penetration, digital literacy, and affordability, excluding large portions of

the rural population. Moreover, traditional medicine remains widely practiced, with many

individuals opting for herbal remedies before seeking formal healthcare, which may delay

effective treatment and contribute to complications.

Globally and in Nigeria, the need to monitor and respond to antimicrobial resistance in UTI

pathogens is a critical priority. Studies have shown an upward trend in resistance to first-line

agents like trimethoprim-sulfamethoxazole and fluoroquinolones (Kassa et al., 2023). The

World Health Organization (WHO) has urged member states to include UTI pathogens in

their national antimicrobial resistance action plans. Nigeria’s National Action Plan on

Antimicrobial Resistance (2017–2022) recognized this need, but implementation remains

inconsistent. Hospitals and clinics need support in reporting resistance data, which can inform

treatment guidelines and policy.

The role of health education in UTI management cannot be overstated. Public awareness

campaigns that promote personal hygiene, proper toilet use, hydration, and the dangers of

self-medication are essential. Health workers should be trained not only in clinical

management but also in educating patients to prevent recurrent infections. A study by Eze and

Umeh (2023) found that women who received counseling about UTI prevention during

antenatal visits had a significantly lower incidence of recurrent UTIs compared to those who

did not.

The healthcare system’s response to UTI management requires a multi-faceted and context-

specific approach. Globally, there is progress in diagnostic accuracy and antimicrobial

stewardship, but these advances are not equitably distributed. In Africa and particularly

Nigeria, systemic challenges such as inadequate diagnostic capacity, poor surveillance, high
resistance levels, and insufficient public education continue to undermine effective UTI

control. Addressing these gaps calls for increased investment in health infrastructure, better

policy enforcement, and community-based interventions that empower both healthcare

workers and patients.

2.2 Theoretical Review

2.2.1 Health Belief Model (HBM)

The Health Belief Model (HBM), one of the most widely used frameworks for understanding

health behaviors, provides valuable theoretical insights into the prevalence and management

of urinary tract infections (UTIs) among patients. Developed in the 1950s by social

psychologists Hochbaum, Rosenstock, and Kegels, the HBM proposes that individuals'

health-related behaviors are influenced by their personal beliefs about health conditions,

perceived threats, and the expected benefits of preventive action. According to Champion and

Skinner (2008), the model rests on six key assumptions: perceived susceptibility, perceived

severity, perceived benefits, perceived barriers, cues to action, and self-efficacy.

Application

Applying the HBM to UTI prevalence, several studies have illustrated how patients’ beliefs

directly impact their willingness to engage in health-seeking behavior, particularly in low-

resource settings. For instance, Odetola (2023) utilized the HBM in analyzing patients'

adherence to hygiene practices and their healthcare-seeking behavior in relation to UTI

recurrence in southwestern Nigeria. The study assumed that individuals who perceive

themselves as highly susceptible to UTIs, and who understand the severity of the condition if

untreated, are more likely to engage in preventive behaviors, such as increased water intake,

proper genital hygiene, and timely visits to clinics. Furthermore, perceived benefits like

effective treatment and reduced recurrence were shown to encourage compliance with
prescribed antibiotic regimens. However, perceived barriers such as the cost of healthcare,

stigma, and poor access to diagnostic facilities significantly reduced health-seeking behavior.

The application of the HBM in UTI research is evident in the work of Hassan et al. (2022),

who applied the model to investigate factors influencing UTI prevalence among pregnant

women in northern Nigeria. The authors reported that many of the women were unaware of

their susceptibility to UTIs due to misconceptions and cultural beliefs. Additionally, barriers

such as fear of invasive procedures and mistrust of healthcare providers discouraged early

diagnosis. However, interventions that included health education, counseling, and peer

support significantly increased awareness and perceived self-efficacy, leading to a reduction

in the prevalence of UTIs in the study population.

Similarly, a study by Mwangi and Otieno (2021) in Kenya employed the HBM to understand

adolescents’ perceptions and practices regarding UTIs. The findings suggested that

adolescents with high perceived severity and susceptibility were more likely to adopt

hygienic practices, avoid risk factors such as delaying urination, and seek medical help. Cues

to action, such as school-based health campaigns, played a crucial role in influencing

behavioral change.

Criticism

Despite its usefulness, the HBM has faced several criticisms in its application to UTI

prevalence. One major criticism, as noted by Janz and Becker (2020), is that the model places

too much emphasis on individual beliefs while underestimating the role of social, economic,

and environmental factors. In the context of UTIs, patients in impoverished communities may

recognize the severity of their condition but lack the financial means or social support to

access treatment. Additionally, the model assumes that individuals make rational decisions

based solely on health beliefs, which may not account for habitual behaviors or cultural

norms. For example, in many rural Nigerian communities, traditional remedies are often
preferred to formal medical treatments, regardless of perceived severity or susceptibility

(Adeboye et al., 2023).

Moreover, the HBM’s construct of “self-efficacy” can be complex in practical application.

For UTI patients, particularly those with recurrent infections, previous treatment failures may

lower confidence in effective self-care, thus limiting preventive behavior even when

susceptibility is acknowledged. In these cases, the model may not fully capture the

psychological impact of repeated illness or healthcare system mistrust. The Health Belief

Model provides a robust framework for understanding patient behavior concerning UTIs. It

highlights the importance of individual beliefs in shaping responses to infection risks and

treatment, particularly in diverse populations. However, its limitations suggest a need for

integrative approaches that consider structural and contextual factors. Future UTI

interventions should combine belief-based models with community-driven and system-wide

strategies to improve health outcomes.

2.2.2 Germ Theory of Disease

The Germ Theory of Disease provides a foundational explanation for the origin and spread of

infectious diseases, positing that microorganisms are the primary causative agents of many

human illnesses. Initially formalized by Louis Pasteur and Robert Koch in the 19th century,

the theory transformed medicine by challenging earlier beliefs in miasmas and supernatural

causes of disease. In the context of urinary tract infections (UTIs), the Germ Theory remains

particularly relevant as it frames the condition as an infection caused by specific pathogens,

predominantly Escherichia coli and, in some cases, Klebsiella pneumoniae and Proteus

mirabilis.

Assumption
According to Adewoyin et al. (2022), the central assumption of the Germ Theory in UTI

research is that UTIs arise due to the colonization and multiplication of pathogenic bacteria

within the urinary tract, often ascending from the urethra to the bladder. This microbial origin

explains the symptomatic manifestations of UTIs, such as dysuria, frequency, urgency, and

lower abdominal discomfort. Furthermore, the theory presumes that eliminating these

microorganisms using antibiotics or preventing their entry into the urinary system can

effectively manage or prevent UTIs. It assumes a direct, cause-effect relationship between

pathogen presence and disease manifestation, which has guided diagnostic and treatment

approaches globally.

Application

The application of the Germ Theory in the study of UTI prevalence is evident in diagnostic

and epidemiological research. For instance, Afolabi et al. (2023) applied this framework to

identify uropathogenic strains isolated from patients at a tertiary hospital in Lagos,

confirming that E. coli was the leading cause of infection. Using microbiological culture and

sensitivity tests, the study demonstrated the significance of identifying the causative agents

for effective treatment, aligning with the Germ Theory’s emphasis on pathogen identification.

In a similar vein, Yusuf and Abdulkarim (2023) explored the relationship between personal

hygiene practices and the presence of bacteria in urine samples of women attending antenatal

clinics in northern Nigeria. Their findings indicated that poor hygiene facilitated bacterial

entry, underscoring the preventive dimension of the Germ Theory limiting microbial

exposure reduces infection risks.

Criticism

However, despite its wide acceptance, the Germ Theory has attracted criticism, especially for

its reductionist tendencies. Critics argue that it oversimplifies the complex interaction

between host immunity, environmental factors, and microbial virulence. For example,
Adedoyin and Bello (2022) emphasized that recurrent UTIs in some patients occurred even

after complete bacterial eradication with antibiotics, pointing to factors such as immune

suppression, hormonal changes, or anatomical abnormalities that the Germ Theory does not

fully address. Additionally, the rise of antimicrobial resistance (AMR) complicates the

pathogen-centered framework. The overuse of antibiotics, guided by a strict germ-centric

model, has led to resistant uropathogens, making some UTIs difficult to treat, as noted in the

work of Obasi et al. (2022).

Moreover, the Germ Theory does not account for the asymptomatic bacteriuria observed in

certain populations, such as elderly individuals or pregnant women, where bacteria are

present without causing symptoms. This observation challenges the assumption that the mere

presence of microorganisms equates to disease. Modern understanding increasingly

incorporates concepts of host-pathogen interactions and microbiome balance, suggesting a

need to complement Germ Theory with more holistic models in the case of UTIs.

The Germ Theory of Disease continues to offer a robust theoretical framework for

understanding the microbial causation of UTIs, particularly in identifying pathogens and

guiding antibiotic treatment. Nevertheless, its limitations call for integration with broader

biomedical and social models that consider immunity, environmental exposure, hygiene

behavior, and antibiotic stewardship. As such, contemporary research on the prevalence of

UTIs must extend beyond microbial identification to embrace a multifactorial approach.

2.3 Empirical Review

Author Location Prevalence Methods Sample Size Key Findings

Name Rate
(Year)
Abdullah Shika- 32% Midstream Pregnant E. coli most prevalent;
i (2021) Zaria, urine, culture women resistance to
Nigeria and (number not ampicillin/cotrimoxazole;
sensitivity stated) sensitive to
testing nitrofurantoin/gentamicin
Yaki Jama’a 28.6% Cross- 301 E. coli dominant (45.3%);
(2023) LGA, sectional, pregnant linked to age ≥35, parity ≥4,
Kaduna urine culture women poor hygiene
State
Okwume Enugu, ~85% Comparative 120 Higher polymicrobial infection
(2021) Nigeria (diabetic vs. symptomatic in diabetics; resistance to
non- patients amoxicillin and cefuroxime
diabetic);
urine culture
Clare Awka, ~70% Comparative 200 cases Slightly higher prevalence in
(2021) Nigeria clinical study (diabetics & diabetics; frequent resistance to
non- tetracycline/cotrimoxazole
diabetics)
Ajayi Ado-Ekiti, 8.5% Cross- 1,443 Higher prevalence in females;
(2024) Nigeria sectional; patients common pathogens: E. coli,
hospital and Klebsiella; widespread
community- resistance to ampicillin
based
Ezo Wachemo 21% Cross- 300+ Young age and low income as
(2024) University, sectional, pregnant risk factors; high resistance to
Ethiopia antenatal women ampicillin; nitrofurantoin
screening effective
Onuoha Afikpo, 25% Urine culture 200 E. coli (50%) most frequent;
Onuoha Nigeria and pregnant high sensitivity to
(2014) sensitivity women ciprofloxacin, gentamicin
Nsofor Mekelle 12% Prospective, 400 students Female sex, poor hygiene
(2019) University, asymptomati increased risk; E. coli,
Ethiopia c screening Klebsiella dominant
Irobi Southeast 31% Culture, risk 250 Risk linked to low education,
(2022) Nigeria factor pregnant late gestation; nitrofurantoin,
analysis women ciprofloxacin effective

Interpretation
The sampling differences from the target population shows most studies focused on pregnant

women (Abdullahi, Yaki, Irobi, Ezo, Onuoha), while others examined diabetic and non-

diabetic patients (Okwume, Clare), or general outpatient and community members (Ajayi).
The sample size varied greatly, from 120 in Okwume (hospital-based) to 1,443 in Ajayi

(broader community). The symptomatic and asymptomatic comparison shows Nsofor (2019)

is unique in assessing asymptomatic students, revealing a lower prevalence of 12%.

The diagnostic and methodological approaches shows sll studies used urine culture and

antimicrobial sensitivity testing, though diagnostic criteria such as bacterial count thresholds

were not always explicitly mentioned. Studies like Abdullahi (2021) and Clare (2021)

emphasized sensitivity testing, which is crucial in antibiotic stewardship, while others, such

as Yaki (2023), added risk factor analysis tied to sociodemographics. Comparative studies

(e.g., Clare and Okwume) revealed differences in UTI patterns and resistance profiles

between diabetic and non-diabetic individuals, a less commonly explored dimension in public

health settings.

The geographical and healthcare settings shows hospital-based studies (e.g., Abdullahi, Clare,

Okwume, Ajayi) tended to report higher prevalence rates due to symptomatic participants or

complex cases. Community or mixed settings like Ajayi (2024) and Nsofor (2019) presented

lower prevalence, possibly due to wider sampling, including asymptomatic individuals or

milder cases.

common Findings and Resistance Trends shows Escherichia coli was the most dominant

pathogen across all studies, followed by Klebsiella spp., Proteus spp., and Staphylococcus

aureus. High resistance to ampicillin, cotrimoxazole, and tetracycline was consistent, while

nitrofurantoin, ciprofloxacin, and gentamicin showed better efficacy across most regions.

Studies consistently emphasize the need for routine urine culture and localized antibiotic

policies to combat increasing resistance.

Notable Regional Differences shows while prevalence was relatively consistent in Nigerian

hospital-based studies (~25–32%), diabetic populations (Clare, Okwume) exhibited more

complex, polymicrobial infections. Ethiopian studies (Ezo and Nsofor) noted socioeconomic

status and age as critical risk factors, with slightly lower prevalence rates possibly due to

wider asymptomatic sampling.

2.4 Appraisal of Reviewed Literature

The existing literature on urinary tract infection (UTI) risk factors in Nigeria and other

African countries, while providing a solid understanding of biological and environmental

contributors, exhibits critical methodological weaknesses. Most notably, the majority of

reviewed studies are cross-sectional, offering only snapshots of prevalence rather than

insights into causal relationships or long-term trends. This approach limits the ability to

explain infection recurrence, seasonal variations, or the evolution of resistance.

Furthermore, while antibiotic resistance patterns are frequently reported, there's a significant

gap in studies that deeply investigate the molecular mechanisms driving this resistance,

which hinders the development of targeted pharmacological interventions. There's also a lack

of exploration into community-based interventions and health system responses to the UTI

burden. Although individual-level risk factors are well-articulated, structural barriers like

inadequate laboratory capacity, insufficient surveillance systems, and policy weaknesses are

not adequately addressed.

To address these methodological shortcomings, the study will implement several key

improvements: Unlike the predominantly cross-sectional studies, the research will employ a

longitudinal design. This will enable us to track infection recurrence, observe seasonal

variations in UTI prevalence, and monitor the evolution of antibiotic resistance over time,

providing a more comprehensive understanding of the disease dynamics.

The research will go beyond reporting antibiotic resistance patterns by incorporating

advanced molecular techniques. This will allow the researcher to investigate the specific
molecular mechanisms underlying resistance, paving the way for the development of more

targeted and effective pharmacological interventions. The research will utilize a larger and

more rigorously sampled population to improve the generalizability and statistical power of

the findings, minimizing the limitations of smaller, potentially less representative samples

seen in prior work.

The research will explicitly investigate structural barriers and health system responses to

UTI. This includes assessing laboratory infrastructure, evaluating existing surveillance

systems, and analyzing policy frameworks related to UTI management, offering insights into

systemic improvements needed for better care and prevention. The research will implement

robust sampling methodologies to ensure that the study population accurately reflects the

diversity of the broader population, thereby strengthening the external validity of the results

compared to studies with potentially less rigorous sampling.